Matthew Ginther

Matthew Ginther, PhD, is an associate in Goodwin’s Intellectual Property Litigation practice who represents life sciences and technology clients in complex patent, trade secret, and technology disputes. His practice focuses on high-stakes, multi-forum matters, with particular experience in appellate advocacy and globally coordinated disputes spanning US and international tribunals. He represents clients in disputes involving standard-essential patents and FRAND licensing, including matters with significant cross-border enforcement considerations and substantial damages exposure.

He also advises clients on healthcare enforcement and False Claims Act matters and maintains an active pro bono practice focused on asylum and civil rights.

Matthew’s experience includes litigating complex disputes through the full lifecycle — from complaint through jury trial and appeal, including through final appellate resolution — across federal district courts, the U.S. Court of Appeals for the Federal Circuit, and administrative tribunals such as the PTAB and ITC. He also has significant experience in appellate briefing and strategy in high-value patent matters and coordinating parallel proceedings across multiple jurisdictions.

Representative experience includes:

• Represented a multinational energy company in parallel proceedings before the ITC, the Federal Circuit, and federal district court. 
• Advised a multinational company on cross-border litigation and enforcement strategy in related international proceedings, including coordination of complex judgment enforcement issues. 
• Contributed to appellate strategy and briefing before the U.S. Court of Appeals for the Federal Circuit in a high-profile standard-essential patent dispute involving FRAND licensing, with parallel proceedings in US courts and international tribunals and hundreds of millions of dollars in awarded damages. 
• Represented a medical device company in trade secret litigation, obtaining a preliminary injunction through expedited motion practice and later securing a record-setting jury verdict and permanent injunction against a competitor. 
• Represented a global electronics manufacturer in patent litigation and post-grant proceedings involving advanced consumer technologies, leading to a favorable resolution of all claims. 
• Represented biotechnology and pharmaceutical companies in bet-the-company patent disputes involving novel gene therapies. 
• Represented clients in government investigations and False Claims Act matters involving healthcare and regulatory enforcement, resulting in the government declining to pursue enforcement action.

In 2025, Matthew was selected to serve as a Special Assistant District Attorney for Middlesex County, where he prosecuted hundreds of felony and misdemeanor cases, with a focus on financial crimes. He served as lead counsel in numerous bench and jury trials and regularly litigated evidentiary and dispositive motions on behalf of the Commonwealth of Massachusetts.

Prior to joining Goodwin, Matthew clerked for the Honorable Indira Talwani of the U.S. District Court for the District of Massachusetts. He also clerked at the U.S. Court of Federal Claims in Washington, DC.

During law school, Matthew was a Network Scholar with the MacArthur Foundation Research Network on Law and Neuroscience while concurrently earning his Ph.D. in Neuroscience from Vanderbilt University. His doctoral research focused on functional neuroimaging and computational modeling of brain activity, including large-scale fMRI data analysis using multivariate statistical and machine learning methods. His research has been published in leading scientific journals and continues to be cited extensively in the field.

Matthew has published his research and analysis across a wide range of journals, including the Journal of Neuroscience, Nature Neuroscience, Vanderbilt Law Review, Seton Hall Law Review, Journal of Law and the Biosciences, and the International Encyclopedia of Social and Behavioral Sciences.